These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9625011)

  • 21. Transplanted MHC class I-deficient nonobese diabetic mouse islets are protected from autoimmune injury in diabetic nonobese recipients.
    Prange S; Zucker P; Jevnikar AM; Singh B
    Transplantation; 2001 Apr; 71(7):982-5. PubMed ID: 11349735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice.
    Zhang YC; Pileggi A; Molano RD; Wasserfall C; Campbell-Thompson M; Ricordi C; Atkinson MA; Inverardi L
    Transplantation; 2005 Aug; 80(4):530-3. PubMed ID: 16123729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
    Gysemans C; Stoffels K; Giulietti A; Overbergh L; Waer M; Lannoo M; Feige U; Mathieu C
    Diabetologia; 2003 Aug; 46(8):1115-23. PubMed ID: 12879250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of both rejection and recurrence of autoimmune disease in the NOD/Lt mouse following segmental pancreas transplantation.
    Purcell LJ; Mottram PL
    Transplant Proc; 1995 Jun; 27(3):2166-7. PubMed ID: 7792922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
    Li H; Kaufman CL; Ildstad ST
    Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
    Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
    Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pig islet xenografts are resistant to autoimmune destruction by non-obese diabetic recipients after anti-CD4 treatment.
    Koulmanda M; Qipo A; Smith RN; Auchincloss H
    Xenotransplantation; 2003 Mar; 10(2):178-84. PubMed ID: 12588650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of streptozotocin on autoimmune diabetes in NOD mice.
    Koulmanda M; Qipo A; Auchincloss H; Smith RN
    Clin Exp Immunol; 2003 Nov; 134(2):210-6. PubMed ID: 14616779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ingested interferon-alpha prevents allograft islet transplant rejection.
    Brod SA; Katz S; Phan T; Stepkowski S
    Transplantation; 2000 May; 69(10):2162-6. PubMed ID: 10852617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
    Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
    Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOD mice have a generalized defect in their response to transplantation tolerance induction.
    Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
    Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ; Mottram PL; Mandel TE
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of transplantation site and culture pretreatment on islet xenograft survival (rat to mouse) in experimental diabetes without immunosuppression of the host.
    Jaeger C; Wöhrle M; Bretzel RG; Federlin K
    Acta Diabetol; 1994 Dec; 31(4):193-7. PubMed ID: 7888689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.